1323077-89-9
1323077-89-9
Chemical Structure
Enzaplatovir
Synonym(s): BTA-C585
- CAS No.: 1323077-89-9
- Formula:C20H19N5O3
- Molecular Weight:377.40
IUPAC Name: (R)-1-(3-methylisoxazole-4-carbonyl)-10a-(6-methylpyridin-3-yl)-2,3,10,10a-tetrahydro-1H,5H-imidazo[1,2-a]pyrrolo[1,2-d]pyrazin-5-one
InChIKey: KUDXTBCRESIJFH-FQEVSTJZSA-N
SMILES: O=C(C1=CON=C1C)N2[C@](CN3C4=CC=C3)(C(C=C5)=CN=C5C)N(CC2)C4=O
Biological Activity: Enzaplatovir (BTA-C585) is an orally bioavailable Inhibitor for respiratory syncytial virus (RSV) infection[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Enzaplatovir | 99.98% | Enzaplatovir (BTA-C585) is an orally bioavailable Inhibitor for respiratory syncytial virus (RSV) infection. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Enzaplatovir (Standard) | ≥98% | Enzaplatovir (Standard) is the analytical standard of Enzaplatovir (HY-109004). This product is intended for research and analytical applications. Enzaplatovir (BTA-C585) is an orally bioavailable Inhibitor for respiratory syncytial virus (RSV) infection. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
